Itriglumide T27640
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Itriglumide, a CCK2 receptor antagonist, is used potentially for the treatment of peptic ulcers, dyspepsia, and gastroesophageal reflux disease (GERD).
CAS nr:
201605-51-8
Purity:
98%
Molecular Weight:
526,68
SMILES:
O=C(O)C[C@H](C1=C2C=CC=CC2=CC=C1)CC(NC3=C(C)C=C(C)C=C3C(N(CC4)CCC54CCCC5)=O)=O
Formula:
C33H38N2O4
Pathway:
Target:
